ym 09151-2 has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, T; Itoh, M; Nakajima, T; Nimura, T; Shirane, R; Yamaguchi, K; Yoshimoto, T | 1 |
| Guan, HC; Niznik, HB; Seeman, P; Van Tol, HH | 1 |
| Berciano, J; Figols, J; González, AM; Pascual, J; Pazos, A | 1 |
| Augood, SJ; Emson, PC; Hollingsworth, ZR; Penney, JB; Standaert, DG | 1 |
4 other study(ies) available for ym 09151-2 and Parkinson Disease
| Article | Year |
|---|---|
The impact of stereotactic pallidal surgery on the dopamine D2 receptor in Parkinson disease: a positron emission tomography study.
Topics: Aged; Benzamides; Dopamine Antagonists; Electric Stimulation Therapy; Female; Globus Pallidus; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Putamen; Receptors, Dopamine D2; Recovery of Function; Stereotaxic Techniques; Tomography, Emission-Computed | 2003 |
Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
Topics: Animals; Benzamides; Corpus Striatum; Dopamine D2 Receptor Antagonists; Humans; In Vitro Techniques; Kinetics; Parkinson Disease; Pituitary Gland, Anterior; Pyrrolidines; Raclopride; Rats; Receptors, Dopamine; Receptors, Dopamine D4; Salicylamides; Schizophrenia; Spiperone; Swine; Tomography, Emission-Computed | 1993 |
Loss of dopamine uptake sites and dopamine D2 receptors in striatonigral degeneration.
Topics: Aged; Autoradiography; Benzamides; Cadaver; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Putamen; Receptors, Dopamine D2; Reference Values; Striatonigral Degeneration | 2000 |
Localization of dopaminergic markers in the human subthalamic nucleus.
Topics: Benzamides; Benzazepines; Biomarkers; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Humans; Mazindol; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Subthalamic Nucleus; Tyrosine 3-Monooxygenase | 2000 |